Cite
HARVARD Citation
Colchester, N. et al. (2022). 089 R-CP chemoimmunotherapy in IgM paraproteinaemic neuropathy produces improvements in serological, neurological and neurophysiological outcomes. Journal of neurology, neurosurgery and psychiatry. 93 (6), pp. A39-A40. [Online].